Strange bedfellows

Comment

S M Grunberg. J Clin Oncol. 1996 Mar.

. 1996 Mar;14(3):1042-3.

doi: 10.1200/JCO.1996.14.3.1042.

No abstract available

Comment on

Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials.
Bennett CL, Smith TJ, George SL, Hillner BE, Fleishman S, Niell HB. Bennett CL, et al. J Clin Oncol. 1995 Sep;13(9):2457-63. doi: 10.1200/JCO.1995.13.9.2457. J Clin Oncol. 1995. PMID: 7545222 Review.
Cost-effectiveness analysis: sleeping with an enemy or a friend?
Gulati SC, Bitran JD. Gulati SC, et al. J Clin Oncol. 1995 Sep;13(9):2152-4. doi: 10.1200/JCO.1995.13.9.2152. J Clin Oncol. 1995. PMID: 7666072 No abstract available.
Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer.
Smith TJ, Hillner BE, Neighbors DM, McSorley PA, Le Chevalier T. Smith TJ, et al. J Clin Oncol. 1995 Sep;13(9):2166-73. doi: 10.1200/JCO.1995.13.9.2166. J Clin Oncol. 1995. PMID: 7666075 Clinical Trial.